Jens Lohrmann

3.0k total citations
13 papers, 321 citations indexed

About

Jens Lohrmann is a scholar working on Surgery, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jens Lohrmann has authored 13 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 5 papers in Molecular Biology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jens Lohrmann's work include Lipoproteins and Cardiovascular Health (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Lipid metabolism and disorders (3 papers). Jens Lohrmann is often cited by papers focused on Lipoproteins and Cardiovascular Health (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Lipid metabolism and disorders (3 papers). Jens Lohrmann collaborates with scholars based in Germany, United States and Switzerland. Jens Lohrmann's co-authors include Thomas K. Nordt, Giso Feussner, Claudia Keitel, Jörg Kudla, Eduardo Zabaleta, E. Schäfer, Uta Sweere, Klaus Harter, László Kozma‐Bognár and Isabel Bäurle and has published in prestigious journals such as European Heart Journal, Journal of Lipid Research and Clinical Chemistry.

In The Last Decade

Jens Lohrmann

13 papers receiving 311 citations

Peers

Countries citing papers authored by Jens Lohrmann

Since Specialization

Citations

This map shows the geographic impact of Jens Lohrmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens Lohrmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens Lohrmann more than expected).

Fields of papers citing papers by Jens Lohrmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens Lohrmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens Lohrmann. The network helps show where Jens Lohrmann may publish in the future.

Co-authorship network of co-authors of Jens Lohrmann

This figure shows the co-authorship network connecting the top 25 collaborators of Jens Lohrmann. A scholar is included among the top collaborators of Jens Lohrmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens Lohrmann. Jens Lohrmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Validation of the Canadian syncope risk score in a large prospective international multicenter study 2020 ·European Heart Journal ·Tobias Zimmermann, Jeanne du Fay de Lavallaz, (unknown), (unknown), Michael Freese, (unknown), Pedro López‐Ayala, (unknown), Jasper Boeddinghaus, Thomas Nestelberger, Patrick Badertscher, Jens Lohrmann, Raphael Twerenbold, (unknown), Christian Mueller	2
2	Rupture of an aneurysm of the noncoronary sinus of Valsalva into the right atrium 2007 ·European Journal of Echocardiography ·(unknown), (unknown), Jens Lohrmann, C Bode, (unknown)	6
3	Blockade of interleukin-13-mediated cell activation by a novel inhibitory antibody to human IL-13 receptor α1 2005 ·Molecular Immunology ·S. Krause, Jochen Behrends, Andreas Borowski, Jens Lohrmann, Siegfried Lang, Daniel Myrtek, (unknown), J. Christian Virchow, Werner Luttmann, K. Friedrich	18
4	Direct attenuation of plasminogen activator inhibitor type-1 expression in human adipose tissue by thiazolidinediones 2004 ·Thrombosis and Haemostasis ·(unknown), Jens Lohrmann, Sandra Ernst, Burton E. Sobel, Christoph Bode, Thomas K. Nordt, Andreas Zirlik	55
5	Effects of apolipoprotein A‐IV genotype on glucose and plasma lipoprotein levels 2002 ·Clinical Genetics ·(unknown), José M. Ordovás, Zhen Sun, (unknown), Jens Lohrmann, Giso Feussner, Stefania Lamon‐Fava, (unknown)	10
6	Regulation of PAI-1 Expression by Genetic Polymorphisms 2001 ·Thrombosis Research ·Thomas K. Nordt, Jens Lohrmann, (unknown)	38
7	The response regulator ARR2: a pollen-specific transcription factor involved in the expression of nuclear genes for components of mitochondrial Complex I in Arabidopsis 2001 ·Molecular Genetics and Genomics ·Jens Lohrmann, Uta Sweere, Eduardo Zabaleta, Isabel Bäurle, Claudia Keitel, László Kozma‐Bognár, Axel Brennicke, E. Schäfer, Jörg Kudla, Klaus Harter	112
8	Molecular basis of type III hyperlipoproteinemia in Germany 1998 ·Human Mutation ·Giso Feussner, (unknown), Michael M. Hoffmann, Jens Lohrmann, Heinrich Wieland, Winfried März	30
9	Molecular basis of type III hyperlipoproteinemia in Germany 1998 ·Human Mutation ·Giso Feussner, (unknown), Michael M. Hoffmann, Jens Lohrmann, Heinrich Wieland, Winfried März	3
10	Comparative effects of bezafibrate and micronised fenofibrate in patients with type III hyperlipoproteinemia. 1997 ·PubMed ·Giso Feussner, Barbara E. Kurth, Jens Lohrmann	8
11	Prevalence and association of atherosclerosis at three different arterial sites in patients with type III hyperlipoproteinemia 1996 ·Atherosclerosis ·Jürgen Dobmeyer, Jens Lohrmann, Giso Feussner	16
12	Apolipoprotein E5 (Glu212–>Lys): increased binding to cell surface proteoglycans but decreased uptake and lysosomal degradation in cultured fibroblasts. 1996 ·Journal of Lipid Research ·Giso Feussner, Hubert Scharnagl, Christina Rebecca Scherbaum, (unknown), Jürgen Dobmeyer, Jens Lohrmann, Heinrich Wieland, Winfried März	20
13	Rapid and reliable identification of human apolipoprotein E1 (Gly127-->Asp, Arg158-->Cys) variant 1995 ·Clinical Chemistry ·Giso Feussner, Jens Lohrmann, Jürgen Dobmeyer	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact